Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Denise S. Uyar MD


Institution: Medical College of Wisconsin
Department: Obstetrics and Gynecology
Division: Gynecologic Oncology
Program: Gynecological Oncology

Member of the Cancer Center

Publications (21)

  • A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive TP53-mutant Ovarian Cancer. (Oza AM, Estevez-Diz M, Grischke EM, Hall M, Marmé F, Provencher D, Uyar D, Weberpals JI, Wenham RM, Laing N, Tracy M, Freshwater T, Lee MA, Liu J, Qiu J, Rose S, Rubin EH, Moore K) Clin Cancer Res 2020 Sep 15;26(18):4767-4776 PMID: 32611648 07/03/2020    
  • OVARIAN GRANULOSA CELL TUMOR IN A PATIENT WITH A PATHOGENIC VARIANT IN THE CDC73 GENE (HYPERPARATHYROIDISM-JAW TUMOR SYNDROME). (Sirbiladze RL, Uyar D, Geurts JL, Shaker JL) AACE Clin Case Rep 2019 May-Jun;5(3):e222-e225 PMID: 31967039 PMCID: PMC6876943 01/23/2020    
  • SOX11 hypermethylation as a tumor biomarker in endometrial cancer. (Shan T, Uyar DS, Wang LS, Mutch DG, Huang TH, Rader JS, Sheng X, Huang YW) Biochimie 2019 Jul;162:8-14 PMID: 30935961 PMCID: PMC6561798 SCOPUS ID: 2-s2.0-85063759067 04/03/2019       1 Citation
  • Adipose-only sentinel lymph nodes: a finding during the adaptation of a sentinel lymph node mapping algorithm with indocyanine green in women with endometrial cancer. (Harold JA, Uyar D, Rader JS, Bishop E, Nugent M, Simpson P, Bradley WH) Int J Gynecol Cancer 2019 01;29(1):53-59 PMID: 30640684 SCOPUS ID: 2-s2.0-85060023480 01/15/2019    
  • Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001). (Konstantinopoulos PA, Brady WE, Farley J, Armstrong A, Uyar DS, Gershenson DM) Gynecol Oncol 2018 07;150(1):9-13 PMID: 29739622 PMCID: PMC6365003 SCOPUS ID: 2-s2.0-85046757642 05/10/2018       14 Citations
  • Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer. (Uyar D, Neary J, Monroe A, Nugent M, Simpson P, Geurts JL) Gynecol Oncol 2018 06;149(3):565-569 PMID: 29653687 SCOPUS ID: 2-s2.0-85045079578 04/15/2018       8 Citations
  • Integrated genomic and molecular characterization of cervical cancer. (Cancer Genome Atlas Research Network, Albert Einstein College of Medicine, Analytical Biological Services, Barretos Cancer Hospital, Baylor College of Medicine, Beckman Research Institute of City of Hope, Buck Institute for Research on Aging, Canada's Michael Smith Genome Sciences Centre, Harvard Medical School, Helen F. Graham Cancer Center &Research Institute at Christiana Care Health Services, HudsonAlpha Institute for Biotechnology, ILSbio, LLC, Indiana University School of Medicine, Institute of Human Virology, Institute for Systems Biology, International Genomics Consortium, Leidos Biomedical, Massachusetts General Hospital, McDonnell Genome Institute at Washington University, Medical College of Wisconsin, Medical University of South Carolina, Memorial Sloan Kettering Cancer Center, Montefiore Medical Center, NantOmics, National Cancer Institute, National Hospital, Abuja, Nigeria, National Human Genome Research Institute, National Institute of Environmental Health Sciences, National Institute on Deafness &Other Communication Disorders, Ontario Tumour Bank, London Health Sciences Centre, Ontario Tumour Bank, Ontario Institute for Cancer Research, Ontario Tumour Bank, The Ottawa Hospital, Oregon Health &Science University, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, SRA International, St Joseph's Candler Health System, Eli &Edythe L. Broad Institute of Massachusetts Institute of Technology &Harvard University, Research Institute at Nationwide Children's Hospital, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, University of Bergen, University of Texas MD Anderson Cancer Center, University of Abuja Teaching Hospital, University of Alabama at Birmingham, University of California, Irvine, University of California Santa Cruz, University of Kansas Medical Center, University of Lausanne, University of New Mexico Health Sciences Center, University of North Carolina at Chapel Hill, University of Oklahoma Health Sciences Center, University of Pittsburgh, University of São Paulo, Ribeir ão Preto Medical School, University of Southern California, University of Washington, University of Wisconsin School of Medicine &Public Health, Van Andel Research Institute, Washington University in St Louis) Nature 2017 03 16;543(7645):378-384 PMID: 28112728 PMCID: PMC5354998 SCOPUS ID: 2-s2.0-85016138846 01/24/2017       418 Citations
  • A prospective pilot study on the incidence of post-operative lymphedema in women with endometrial cancer. (Hopp EE, Osborne JL, Schneider DK, Bojar CJ, Uyar DS) Gynecol Oncol Rep 2016 Jan;15:25-8 PMID: 26937484 PMCID: PMC4750017 03/05/2016    
  • Ovarian cancer (Rose PG, Uyar DS) Clinical Gynecology, Second Edition 1 January 2015:790-812 SCOPUS ID: 2-s2.0-84952887800 01/01/2015    
  • Peer teen advocates and increased awareness of human papillomavirus and vaccination among urban youth (Uyar D, Young S, Tyree-Francis S, Kiepczynski MA) Public Health: Improving Health via Inter-Professional Collaborations July 01, 2014:85-94 SCOPUS ID: 2-s2.0-84952947017 07/01/2014    
  • 3-T MRI-based adaptive brachytherapy for cervix cancer: treatment technique and initial clinical outcomes. (Kharofa J, Morrow N, Kelly T, Rownd J, Paulson E, Rader J, Uyar D, Bradley W, Erickson B) Brachytherapy 2014 Jul-Aug;13(4):319-25 PMID: 24837024 SCOPUS ID: 2-s2.0-84902539256 05/20/2014       22 Citations
  • Hypermethylation of miR-203 in endometrial carcinomas. (Huang YW, Kuo CT, Chen JH, Goodfellow PJ, Huang TH, Rader JS, Uyar DS) Gynecol Oncol 2014 May;133(2):340-5 PMID: 24530564 PMCID: PMC4015135 SCOPUS ID: 2-s2.0-84899624704 02/18/2014       42 Citations
  • Genomics of cervical cancer and the role of human papillomavirus pathobiology. (Uyar D, Rader J) Clin Chem 2014 Jan;60(1):144-6 PMID: 24046199 09/21/2013    
  • Multifocal vulvar smooth muscle tumor with an unusual intravascular growth pattern and multiple local recurrences in a 10-year-old child: a diagnostic dilemma. (Harrington A, Bell E, Suchi M, Behmaram B, Uyar D) Pediatr Dev Pathol 2011 May-Jun;14(3):235-9 PMID: 21090988 SCOPUS ID: 2-s2.0-80054051952 11/26/2010       1 Citation
  • Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer. (Uyar D, Frasure HE, Markman M, von Gruenigen VE) Gynecol Oncol 2005 Sep;98(3):403-8 PMID: 16000216 SCOPUS ID: 2-s2.0-23844523788 07/08/2005       93 Citations
  • Cardiac safety profile of prolonged (>or=6 cycles) pegylated liposomal doxorubicin administration in patients with gynecologic malignancies. (Uyar D, Kulp B, Peterson G, Zanotti K, Markman M, Belinson J) Gynecol Oncol 2004 Jul;94(1):147-51 PMID: 15262133 SCOPUS ID: 2-s2.0-3242703387 07/21/2004       37 Citations
  • False positive diagnosis in conventional and liquid-based cervical specimens. (Mount S, Harmon M, Eltabbakh G, Uyar D, Leiman G) Acta Cytol 2004 May-Jun;48(3):363-71 PMID: 15192952 06/15/2004    
  • Apoptotic pathways of epothilone BMS 310705. (Uyar D, Takigawa N, Mekhail T, Grabowski D, Markman M, Lee F, Canetta R, Peck R, Bukowski R, Ganapathi R) Gynecol Oncol 2003 Oct;91(1):173-8 PMID: 14529678 SCOPUS ID: 2-s2.0-0141757448 10/08/2003       21 Citations
  • Positive predictive value of liquid-based and conventional cervical Papanicolaou smears reported as malignant. (Uyar DS, Eltabbakh GH, Mount SL) Gynecol Oncol 2003 May;89(2):227-32 PMID: 12713984 SCOPUS ID: 2-s2.0-0037405473 04/26/2003       24 Citations
  • Integration of 28 STSs into the physical map of human chromosome 18. (Gerken S, Fish K, Uyar D, Polymeropoulos MH, Bradley P, White R, Overhauser J, Silverman GA) Genomics 1994 Dec;24(3):612-3 PMID: 7713522 12/01/1994       10 Citations
  • Regional localization of 56 new human chromosome 18-specific yeast artificial chromosomes. (Chang E, Luna J, Giacalone J, Uyar D, Silverman GA, Francke U) Cytogenet Cell Genet 1994;65(1-2):136-9 PMID: 8404067 01/01/1994       3 Citations
  • Last update: 08/17/2020
    jenkins-FCD Prod-482 91ad8a360b6da540234915ea01ff80e38bfdb40a